Kevin D. Bunker's most recent trade in Zentalis Pharmaceuticals Inc was a trade of 24,158 Common Stock done . Disclosure was reported to the exchange on Dec. 20, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zentalis Pharmaceuticals Inc | Kevin Bunker D. | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Dec 2023 | 24,158 | 834,931 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 30.02 per share. | 26 May 2023 | 80,000 | 15,000 | - | 30.0 | 2,401,248 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 19.98 per share. | 13 Feb 2023 | 6,500 | 865,157 | - | 20.0 | 129,873 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.42 per share. | 13 Feb 2023 | 3,807 | 871,657 | - | 20.4 | 77,756 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 132,646 | 132,646 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 91,354 | 875,464 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2023 | 30,000 | 784,110 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 50,000 | 814,110 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 10 Aug 2022 | 5,000 | 95,000 | - | 30 | 150,000 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 20 Jul 2022 | 5,000 | 100,000 | - | 30 | 150,000 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.01 per share. | 13 Jul 2022 | 3,290 | 105,000 | - | 30.0 | 98,721 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.02 per share. | 13 Jul 2022 | 1,710 | 108,290 | - | 30.0 | 51,341 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.07 per share. | 05 Jul 2022 | 25,000 | 110,000 | - | 30.1 | 751,653 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.37 per share. | 11 Apr 2022 | 4,600 | 135,400 | - | 30.4 | 139,709 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 32.40 per share. | 11 Apr 2022 | 300 | 135,100 | - | 32.4 | 9,720 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 33.16 per share. | 11 Apr 2022 | 100 | 135,000 | - | 33.2 | 3,316 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 48.72 per share. | 21 Mar 2022 | 5,556 | 144,444 | - | 48.7 | 270,679 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 49.50 per share. | 21 Mar 2022 | 4,444 | 140,000 | - | 49.5 | 219,990 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 47.18 per share. | 10 Mar 2022 | 4,301 | 151,699 | - | 47.2 | 202,901 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 46.23 per share. | 10 Mar 2022 | 4,000 | 156,000 | - | 46.2 | 184,935 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 47.99 per share. | 10 Mar 2022 | 1,699 | 150,000 | - | 48.0 | 81,538 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 48.95 per share. | 22 Feb 2022 | 6,343 | 162,857 | - | 48.9 | 310,463 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 49.92 per share. | 22 Feb 2022 | 2,451 | 160,406 | - | 49.9 | 122,351 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 47.08 per share. | 22 Feb 2022 | 800 | 169,200 | - | 47.1 | 37,663 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 50.39 per share. | 22 Feb 2022 | 406 | 160,000 | - | 50.4 | 20,457 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 52,745 | 52,745 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 22,481 | 768,798 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 54.20 per share. | 10 Feb 2022 | 3,321 | 171,239 | - | 54.2 | 180,003 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 53.19 per share. | 10 Feb 2022 | 3,074 | 174,560 | - | 53.2 | 163,502 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 50.29 per share. | 10 Feb 2022 | 2,863 | 764,110 | - | 50.3 | 143,970 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 52.15 per share. | 10 Feb 2022 | 2,366 | 177,634 | - | 52.2 | 123,394 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 50.16 per share. | 10 Feb 2022 | 1,622 | 767,176 | - | 50.2 | 81,366 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 54.96 per share. | 10 Feb 2022 | 1,239 | 170,000 | - | 55.0 | 68,097 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 50.75 per share. | 10 Feb 2022 | 203 | 766,973 | - | 50.7 | 10,302 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 60.20 per share. | 20 Jan 2022 | 6,537 | 180,710 | - | 60.2 | 393,505 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 59.17 per share. | 20 Jan 2022 | 2,753 | 187,247 | - | 59.2 | 162,889 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 61.29 per share. | 20 Jan 2022 | 710 | 180,000 | - | 61.3 | 43,518 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jan 2022 | 8,750 | 746,317 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 67.24 per share. | 10 Jan 2022 | 3,146 | 196,854 | - | 67.2 | 211,528 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 68.05 per share. | 10 Jan 2022 | 2,807 | 194,047 | - | 68.0 | 191,013 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 70.02 per share. | 10 Jan 2022 | 2,212 | 190,000 | - | 70.0 | 154,893 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 69.03 per share. | 10 Jan 2022 | 1,835 | 192,212 | - | 69.0 | 126,663 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 72.10 per share. | 10 Dec 2021 | 5,117 | 210,400 | - | 72.1 | 368,951 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 71.17 per share. | 10 Dec 2021 | 4,049 | 215,517 | - | 71.2 | 288,151 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 70.29 per share. | 10 Dec 2021 | 434 | 219,566 | - | 70.3 | 30,505 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 73.75 per share. | 10 Dec 2021 | 400 | 210,000 | - | 73.8 | 29,500 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 75.99 per share. | 22 Nov 2021 | 10,000 | 220,000 | - | 76.0 | 759,937 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2021 | 240,000 | 240,000 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2021 | 240,000 | 755,067 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 78.15 per share. | 10 Nov 2021 | 10,000 | 230,000 | - | 78.1 | 781,471 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 66.89 per share. | 01 Oct 2021 | 3,679 | 204 | - | 66.9 | 246,075 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 65.80 per share. | 01 Oct 2021 | 3,121 | 3,883 | - | 65.8 | 205,362 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 64.73 per share. | 01 Oct 2021 | 1,416 | 7,004 | - | 64.7 | 91,659 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Oct 2021 | 350 | 995,067 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Oct 2021 | 350 | 350 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 67.45 per share. | 01 Oct 2021 | 204 | 0 | - | 67.4 | 13,759 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 67.77 per share. | 01 Sep 2021 | 4,198 | 8,820 | - | 67.8 | 284,489 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 67.08 per share. | 01 Sep 2021 | 3,822 | 13,018 | - | 67.1 | 256,362 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 68.58 per share. | 01 Sep 2021 | 400 | 8,420 | - | 68.6 | 27,432 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 51.35 per share. | 02 Aug 2021 | 3,728 | 18,393 | - | 51.3 | 191,431 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 49.92 per share. | 02 Aug 2021 | 3,139 | 22,121 | - | 49.9 | 156,706 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 52.41 per share. | 02 Aug 2021 | 1,246 | 17,147 | - | 52.4 | 65,300 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 53.32 per share. | 02 Aug 2021 | 307 | 16,840 | - | 53.3 | 16,368 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 46.84 per share. | 06 Jul 2021 | 12,947 | 995,841 | - | 46.8 | 606,391 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 46.78 per share. | 06 Jul 2021 | 4,906 | 1,014,747 | - | 46.8 | 229,515 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 47.28 per share. | 06 Jul 2021 | 1,842 | 1,010,294 | - | 47.3 | 87,090 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 47.76 per share. | 06 Jul 2021 | 1,506 | 1,008,788 | - | 47.8 | 71,930 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 47.17 per share. | 06 Jul 2021 | 1,349 | 1,013,398 | - | 47.2 | 63,628 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 46.08 per share. | 06 Jul 2021 | 1,166 | 1,012,136 | - | 46.1 | 53,727 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 47.33 per share. | 06 Jul 2021 | 800 | 995,041 | - | 47.3 | 37,864 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 49.20 per share. | 06 Jul 2021 | 200 | 994,841 | - | 49.2 | 9,841 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 48.83 per share. | 06 Jul 2021 | 96 | 1,013,302 | - | 48.8 | 4,688 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 51.30 per share. | 01 Jul 2021 | 4,127 | 27,153 | - | 51.3 | 211,733 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 50.18 per share. | 01 Jul 2021 | 2,400 | 31,280 | - | 50.2 | 120,440 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 52.18 per share. | 01 Jul 2021 | 1,473 | 25,680 | - | 52.2 | 76,858 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 53.18 per share. | 01 Jul 2021 | 420 | 25,260 | - | 53.2 | 22,336 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 54.00 per share. | 01 Jun 2021 | 7,571 | 34,529 | - | 54.0 | 408,867 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 54.86 per share. | 01 Jun 2021 | 849 | 33,680 | - | 54.9 | 46,574 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 59.91 per share. | 03 May 2021 | 4,567 | 43,223 | - | 59.9 | 273,630 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 58.09 per share. | 03 May 2021 | 1,630 | 47,790 | - | 58.1 | 94,679 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 60.23 per share. | 03 May 2021 | 1,123 | 42,100 | - | 60.2 | 67,639 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 57.12 per share. | 03 May 2021 | 1,100 | 49,420 | - | 57.1 | 62,836 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 13 Apr 2021 | 3,810 | 50,520 | - | 45 | 171,450 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 43.36 per share. | 05 Apr 2021 | 15,361 | 1,019,928 | - | 43.4 | 666,053 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 43.37 per share. | 05 Apr 2021 | 9,024 | 1,035,440 | - | 43.4 | 391,332 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.07 per share. | 05 Apr 2021 | 400 | 54,330 | - | 45.1 | 18,028 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 43.26 per share. | 05 Apr 2021 | 275 | 1,019,653 | - | 43.3 | 11,897 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 44.22 per share. | 05 Apr 2021 | 97 | 1,035,343 | - | 44.2 | 4,289 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.06 per share. | 05 Apr 2021 | 54 | 1,035,289 | - | 45.1 | 2,433 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 43.09 per share. | 01 Apr 2021 | 2,436 | 56,504 | - | 43.1 | 104,978 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 43.88 per share. | 01 Apr 2021 | 1,674 | 54,830 | - | 43.9 | 73,449 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 44.90 per share. | 01 Apr 2021 | 100 | 54,730 | - | 44.9 | 4,490 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.24 per share. | 10 Mar 2021 | 4,720 | 58,940 | - | 45.2 | 213,542 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.07 per share. | 03 Mar 2021 | 3,700 | 63,660 | - | 45.1 | 166,747 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 41.65 per share. | 01 Mar 2021 | 4,210 | 67,360 | - | 41.7 | 175,352 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 56,250 | 56,250 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 18,750 | 1,044,464 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 37.29 per share. | 01 Feb 2021 | 2,441 | 73,339 | - | 37.3 | 91,018 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 37.82 per share. | 01 Feb 2021 | 1,769 | 71,570 | - | 37.8 | 66,901 | Common Stock |
| Zentalis Pharmaceuticals Inc | Kevin D. Bunker | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 52.42 per share. | 04 Jan 2021 | 9,701 | 1,033,338 | - | 52.4 | 508,529 | Common Stock |